STOCK TITAN

NLS Pharmaceutics Ltd. Warrant (NLSPW) Net Income by Year

NLSPW

NLS Pharmaceutics Ltd. Warrant reported a net loss of $8.3M in fiscal year 2025. This represents a decrease of 319.0% from the prior fiscal year. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters NLS Pharmaceutics Ltd. Warrant has filed alongside them.

FY2025 annual
Net Income -$8.3M
YoY -319.0%
Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

NLSPW Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY22FY21FY20FY19FY18
Net Income-$8.3M-319.0%-$2.0M+40.6%-$3.3M+79.8%-$16.5M-38.1%-$11.9M-317.5%-$2.9MN/A-$5.1M

NLSPW Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2510-KQ2'2510-QQ4'2410-KQ2'24Q4'23Q2'23Q4'22Q2'22Q4'21Q2'21Q4'20Q4'19
Net IncomeN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More NLS Pharmaceutics Ltd. Warrant financials

Frequently Asked Questions

What was NLS Pharmaceutics Ltd. Warrant's net income in fiscal year 2025?

NLS Pharmaceutics Ltd. Warrant reported a net loss of $8.3M in fiscal year 2025.

How fast is NLS Pharmaceutics Ltd. Warrant's net income growing?

NLS Pharmaceutics Ltd. Warrant (NLSPW) net income fell by 319.0% year over year, from -$2.0M to -$8.3M in fiscal year 2025.

How has NLS Pharmaceutics Ltd. Warrant's net income changed over the years?

Across the 8 fiscal years this page covers, NLS Pharmaceutics Ltd. Warrant (NLSPW) net income went from -$5.1M in fiscal year 2018 to -$8.3M in fiscal year 2025.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what NLS Pharmaceutics Ltd. Warrant (NLSPW) reported on that line in every period on record.